- Home
- Equipment
- usa california
- risk assessment
Refine by
Risk Assessment Equipment Supplied In Usa California
10 equipment items found
by:Accruent based inAustin, TEXAS (USA)
Manage attributes of all network connected medical devices. Conduct risk assessments, reconcile MDS2 data and other security attributes against inventory, and remediate potential risks and vulnerabilities. Automate workflows unique to your ...
Manufactured by:Tempus based inChicago, ILLINOIS (USA)
Providing risk-assessment for hereditary cancer syndromes for patients and their families. xG+ (extended hereditary cancers): Covers genes associated with multiple hereditary cancer types, including common hereditary cancers (breast, ovarian, colorectal, endometrial, prostate, pancreatic) and others (renal/urinary tract, gastric, melanoma, thyroid, endocrine, ...
Manufactured by:Masimo Corp based inIrvine, CALIFORNIA (USA)
Masimo SafetyNet-OPEN is a complete, easy-to-implement solution to help you safely bring people back into the workplace and keep them ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Empower is a genetic test for those who want to know more about their risk of developing cancer, why it might be common in their family, or want to inform treatment options following a cancer diagnosis. Empower screens for genes associated with increased risk for common hereditary cancers. Our Empower multi-cancer panels include commonly screened-for genes associated with 12+ types of ...
Manufactured by:DxTerity Diagnostics Inc. based inRancho Dominguez, CALIFORNIA (USA)
The DxTerity Immunity Assessment Test measures COVID-19 neutralizing antibody levels from a small sample of blood. Knowing your neutralizing antibody levels can help you assess your risk of future symptomatic ...
Manufactured by:PreludeDx based inLaguna Hills, CALIFORNIA (USA)
Predicts radiation benefit. DCISionRT is the only test capable of predicting an individual patient’s benefit from radiation therapy. Using DCISionRT provides you with 10-year Total and Invasive Recurrence Risk after breast conserving surgery as well as surgery with radiation therapy. No other test can do ...
by:BillionToOne Inc. based inMenlo Park, CALIFORNIA (USA)
Shifting the Paradigm of Prenatal Screening: The name of our non-invasive prenatal test (NIPT) is appropriately called “UNITY” as it brings together fetal screening for aneuploidies and recessive conditions. It also represents uniting pregnant patients in more equitable ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Covered by Medicare, Prospera is a transplant rejection assessment test that uses a simple blood draw to evaluate the risk of rejection of a transplanted kidney. Through the use of advanced cell-free DNA technology, Prospera increases a provider’s ability to identify otherwise undetected rejection that might lead to kidney loss. ...
by:Natera, Inc. based inAustin, TEXAS (USA)
Signatera is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment and recurrence monitoring for patients previously diagnosed with cancer, with broad utility for cancer ...
Manufactured by:MDxHealth based inIrvine, CALIFORNIA (USA)
MDxHealth’s technology platform is called methylation-specific PCR (MSP), which is a proprietary DNA-based technology that functions on standard commercial PCR equipment. MSP is extremely powerful and accurate with the ability to detect a single cancer cell among 10,000 healthy cells in any type of bodily fluid or tissue. MDxHealth has patents and other intellectual property on the MSP ...